Media agencies today reported that Joseph Papa, who resigned from troubled pharmaceuticals company Perrigo Co., will join Valeant (NYSE: … More
Tag: Valeant Pharmaceuticals International
Valeant is a House Built on Quicksand
Today Valeant Pharmaceuticals International announced a lower earnings forecast and, more importantly, warned that it might miss debt payments. … More
Quick Take: The Problem with Valeant
On 29 February, Valeant Pharmaceuticals International Inc. (NYSE: VRX) admitted that it was under more regulator investigations: “In response to … More
Risk Spotlight 